Therapeutic Targeting of the Colorectal Tumor Stroma

被引：60

作者：

Fridman, Wolf H. ^{[1
]}

Miller, Ian S. ^{[2
]}

Sautes-Fridman, Catherine ^{[1
]}

Byrne, Annette T. ^{[2
]}

机构：

[1] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,Inflammat Complement & Canc Team, Paris, France

[2] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland

来源：

GASTROENTEROLOGY | 2020年 / 158卷 / 02期

基金：

爱尔兰科学基金会;

关键词：

CRC; MSI; Matrix; Microenvironment; ENDOTHELIAL GROWTH-FACTOR; CONSENSUS MOLECULAR SUBTYPES; FOLFIRI PLUS BEVACIZUMAB; COLON-CANCER; 1ST-LINE TREATMENT; IMMUNE CONTEXTURE; TGF-BETA; T-CELLS; MICROVESSEL DENSITY; RANDOMIZED-TRIAL;

D O I：

10.1053/j.gastro.2019.09.045

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal tumors have been classified based on histologic factors, genetic factors, and consensus molecular subtypes, all of which affect the tumor microenvironment. Elements of the tumor microenvironment serve as therapeutic targets and might be used as prognostic factors. For example, immune checkpoint inhibitors are used to treat tumors with microsatellite instability, and anti-angiogenic agents may be used in combination with other drugs to slow or inhibit tumor growth. We review the features of the colorectal tumor stroma that are associated with patient outcomes and discuss potential therapeutic agents that target these features.

引用

页码：303 / 321

页数：19

共 169 条

[1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].

Achen, MG ;

Jeltsch, M ;

Kukk, E ;

Mäkinen, T ;

Vitali, A ;

Wilks, AF ;

Alitalo, K ;

Stacker, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553

[2] Sorafenib (BAY 43-9006, Nexavar®), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature [J].

Adnane, Lila ;

Trail, Pamela A. ;

Taylor, Ian ;

Wilhelm, Scott M. .

REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 :597-+

[3] Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies [J].

Alderdice, Matthew ;

Richman, Susan D. ;

Gollins, Simon ;

Stewart, James P. ;

Hurt, Chris ;

Adams, Richard ;

McCorry, Amy M. B. ;

Roddy, Aideen C. ;

Vimalachandran, Dale ;

Isella, Claudio ;

Medico, Enzo ;

Maughan, Tim ;

McArt, Darragh G. ;

Lawler, Mark ;

Dunne, Philip D. .

JOURNAL OF PATHOLOGY, 2018, 245 (01) :19-28

[4] Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 [J].

Allegra, Carmen J. ;

Rumble, R. Bryan ;

Hamilton, Stanley R. ;

Mangu, Pamela B. ;

Roach, Nancy ;

Hantel, Alexander ;

Schilsky, Richard L. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) :179-+

[5] Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].

Amado, Rafael G. ;

Wolf, Michael ;

Peeters, Marc ;

Van Cutsem, Eric ;

Siena, Salvatore ;

Freeman, Daniel J. ;

Juan, Todd ;

Sikorski, Robert ;

Suggs, Sid ;

Radinsky, Robert ;

Patterson, Scott D. ;

Chang, David D. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634

[6] Evolution of Metastases in Space and Time under Immune Selection [J].

Angelova, Mihaela ;

Mlecnik, Bernhard ;

Vasaturo, Angela ;

Bindea, Gabriela ;

Fredriksen, Tessa ;

Lafontaine, Lucie ;

Buttard, Benedicte ;

Morgand, Erwan ;

Bruni, Daniela ;

Jouret-Mourin, Anne ;

Hubert, Catherine ;

Kartheuser, Alex ;

Humblet, Yves ;

Ceccarelli, Michele ;

Syed, Najeeb ;

Marincola, Francesco M. ;

Bedognetti, Davide ;

Van den Eynde, Marc ;

Galon, Jerome .

CELL, 2018, 175 (03) :751-+

[7] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[8] Precancer in ulcerative colitis: the role of the field effect and its clinical implications [J].

Baker, Kathryn T. ;

Salk, Jesse J. ;

Brentnall, Teresa A. ;

Risques, Rosa Ana .

CARCINOGENESIS, 2018, 39 (01) :11-20

[9] Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature [J].

Baran, Burcin ;

Ozupek, Nazli Mert ;

Tetik, Nihal Yerli ;

Acar, Emine ;

Bekcioglu, Omer ;

Baskin, Yasemin .

GASTROENTEROLOGY RESEARCH, 2018, 11 (04) :264-273

[10] Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression [J].

Becht, Etienne ;

Giraldo, Nicolas A. ;

Lacroix, Laetitia ;

Buttard, Benedicte ;

Elarouci, Nabila ;

Petitprez, Florent ;

Selves, Janick ;

Laurent-Puig, Pierre ;

Sautes-Fridman, Catherine ;

Fridman, Wolf H. ;

de Reynies, Aurelien .

GENOME BIOLOGY, 2016, 17

← 1 2 3 4 5 6 7 8 9 10 →